Isabelle Simoneau

490 total citations
22 papers, 169 citations indexed

About

Isabelle Simoneau is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Isabelle Simoneau has authored 22 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Isabelle Simoneau's work include Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Isabelle Simoneau is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Isabelle Simoneau collaborates with scholars based in France, Belgium and Australia. Isabelle Simoneau's co-authors include Benjamin Bouillet, Bruno Vergès, Jean‐Michel Petit, Laurence Duvillard, Damien Denimal, Serge Monier, Alexia Rouland, Jean-Paul Paı̈s de Barros, Marie‐Claude Brindisi and Laurent Demizieux and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Isabelle Simoneau

20 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Simoneau France 8 87 44 36 32 21 22 169
Larysa Sydorchuk Ukraine 7 58 0.7× 24 0.5× 53 1.5× 37 1.2× 26 1.2× 77 202
Edmund Chan Singapore 8 115 1.3× 75 1.7× 56 1.6× 31 1.0× 21 1.0× 13 232
Michael Fanta Czechia 10 115 1.3× 25 0.6× 60 1.7× 58 1.8× 30 1.4× 36 504
Hamid Alemi United States 9 53 0.6× 16 0.4× 34 0.9× 30 0.9× 22 1.0× 24 219
Pedro Pujante Spain 7 88 1.0× 55 1.3× 21 0.6× 20 0.6× 14 0.7× 35 182
Başak Özgen Saydam Türkiye 10 114 1.3× 32 0.7× 50 1.4× 20 0.6× 39 1.9× 19 244
Keiichiro Kosuge Japan 6 56 0.6× 28 0.6× 23 0.6× 25 0.8× 18 0.9× 7 115
Ahmed Al‐Qaissi United Kingdom 9 66 0.8× 24 0.5× 58 1.6× 12 0.4× 15 0.7× 19 191
Michael Stagliano United States 8 32 0.4× 31 0.7× 28 0.8× 17 0.5× 20 1.0× 13 155

Countries citing papers authored by Isabelle Simoneau

Since Specialization
Citations

This map shows the geographic impact of Isabelle Simoneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Simoneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Simoneau more than expected).

Fields of papers citing papers by Isabelle Simoneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Simoneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Simoneau. The network helps show where Isabelle Simoneau may publish in the future.

Co-authorship network of co-authors of Isabelle Simoneau

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Simoneau. A scholar is included among the top collaborators of Isabelle Simoneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Simoneau. Isabelle Simoneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Paul M., Isabelle Fournel, Alexandre Cochet, et al.. (2025). Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study. Diabetes Research and Clinical Practice. 221. 112017–112017. 1 indexed citations
2.
Rouland, Alexia, Thomas Gautier, Damien Denimal, et al.. (2024). The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes. Metabolites. 14(9). 487–487.
3.
Denimal, Damien, Laurence Duvillard, Béatrice Terriat, et al.. (2024). Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes. Diabetes & Metabolism. 50(4). 101542–101542. 3 indexed citations
4.
Bouillet, Benjamin, Isabelle Simoneau, Sylvain Manfrédi, et al.. (2023). Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring. Acta Diabetologica. 60(4). 545–552. 3 indexed citations
5.
Simoneau, Isabelle, et al.. (2023). Development and Implementation of Workshops to Optimize the Delivery of Vaccination Services in Community Pharmacies: Thinking beyond COVID-19. SHILAP Revista de lepidopterología. 11(4). 129–129. 2 indexed citations
6.
Denimal, Damien, Isabelle Simoneau, Laurent Demizieux, et al.. (2023). Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes. Cardiovascular Diabetology. 22(1). 104–104. 15 indexed citations
7.
Denimal, Damien, Serge Monier, Isabelle Simoneau, et al.. (2022). Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities. The Journal of Clinical Endocrinology & Metabolism. 107(9). e3816–e3823. 17 indexed citations
8.
Denimal, Damien, Serge Monier, Isabelle Simoneau, et al.. (2022). HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control. Cardiovascular Diabetology. 21(1). 154–154. 7 indexed citations
9.
Rouland, Alexia, et al.. (2021). Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion. Clinical Pharmacology Advances and Applications. Volume 13. 33–37. 3 indexed citations
10.
Vergès, Bruno, Jean‐Michel Petit, Isabelle Simoneau, et al.. (2021). Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer. Diabetes & Metabolism. 47(6). 101245–101245. 4 indexed citations
11.
Vergès, Bruno, Alexia Rouland, Benjamin Bouillet, et al.. (2021). Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins. Diabetes & Metabolism. 48(2). 101284–101284. 7 indexed citations
12.
Vergès, Bruno, Alexia Rouland, S. Baillot-Rudoni, et al.. (2020). Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients. Journal of Diabetes Investigation. 12(4). 619–624. 5 indexed citations
13.
Besnard, Philippe, Jeffrey E. Christensen, Arnaud Bernard, et al.. (2020). Identification of an oral microbiota signature associated with an impaired orosensory perception of lipids in insulin-resistant patients. Acta Diabetologica. 57(12). 1445–1451. 10 indexed citations
14.
Rouland, Alexia, Anne-Laure Sberna, Serge Aho, et al.. (2018). Malnutrition in type 2 diabetic patients does not affect healing of foot ulcers. Acta Diabetologica. 56(2). 171–176. 13 indexed citations
15.
Chauvet‐Gélinier, Jean‐Christophe, Cédric Lemogne, Sylviane Ragot, et al.. (2018). Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes. Diabetes & Metabolism. 45(6). 582–585. 3 indexed citations
16.
Vergès, Bruno, Martin Adiels, Jan Borén, et al.. (2016). ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity. The Journal of Clinical Endocrinology & Metabolism. 101(4). 1398–1406. 3 indexed citations
17.
Belykh, Evgenii, Isabelle Simoneau, Kaan Yağmurlu, et al.. (2016). Monsters and the case of L. Joseph: André Feil's thesis on the origin of the Klippel-Feil syndrome and a social transformation of medicine. Neurosurgical FOCUS. 41(1). E3–E3. 4 indexed citations
18.
Vergès, Bruno, Marie‐Christine Iliou, Isabelle Simoneau, et al.. (2015). Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study. BMC Cardiovascular Disorders. 15(1). 64–64. 9 indexed citations
19.
Chauvet‐Gélinier, Jean‐Christophe, Cédric Lemogne, Serge Aho, et al.. (2015). Potential influence of Type A personality on plasma C-reactive protein levels in people with diabetes. Diabetes & Metabolism. 42(2). 88–95. 10 indexed citations
20.
Simoneau, Isabelle, Christiane Mousson, Gerardo Zanetta, E Racadot, & G Rifle. (1998). In vitro study of alloreactivity and microchimerism after injection of dendritic cells and anti-CD4 monoclonal antibody in a combination of Lewis–Wistar Furth rats: preliminary data. Transplantation Proceedings. 30(6). 2857–2858. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026